Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations (vol 110, pg 894, 2014)

被引：2
|
作者：
Hu, S.
Mathijssen, R. H. J.
de Bruijn, P.
Baker, S. D.
Sparreboom, A.
机构：
来源：
BRITISH JOURNAL OF CANCER | 2017年 / 117卷 / 05期
关键词：
D O I：
10.1038/bjc.2017.217
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Correction to: British Journal of Cancer (2014) 110, 894–898. doi:10.1038/bjc.2013.811; published online 7 January 2014 After publication of the above paper in the British Journal of Cancer, a discrepancy was found in the text. The Results section contains the following: ‘As a representative of thisclass of TKIs, sorafenib was further evaluated and found to also potently inhibit the OATP1B1-mediated transport of docetaxel with a half-inhibitory maximum concentration of 6.
引用
收藏
页码：e3 / e3
页数：1
相关论文
共 50 条
  • [41] Multiple phosphorylation of chicken protein tyrosine phosphatase 1 and human protein tyrosine phosphatase 1B by casein kinase II and p60c-src in vitro (vol 246, pg 238, 1998)
    Jung, EJ
    Kang, YS
    Kim, CW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) : 940 - 940
  • [42] Potent non-peptidyl inhibitors of protein tyrosine phosphatase 1B (vol 6, pg 1457, 1998)
    Taylor, SD
    Kotoris, CC
    Dinaut, AN
    Wang, QP
    Ramachandran, C
    Huang, Z
    BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (11) : 2235 - 2235
  • [43] Inhibition of BUB1 Kinase by BAY 1816032 Sensitizes Tumor Cells toward Taxanes, ATR, and PARP Inhibitors In Vitro and In Vivo
    Siemeister, Gerhard
    Mengel, Anne
    Fernandez-Montalvan, Amaury E.
    Bone, Wilhelm
    Schroeder, Jens
    Zitzmann-Kolbe, Sabine
    Briem, Hans
    Prechtl, Stefan
    Holton, Simon J.
    Moenning, Ursula
    von Ahsen, Oliver
    Johanssen, Sandra
    Cleve, Arwed
    Puetter, Vera
    Hitchcock, Marion
    von Nussbaum, Franz
    Brands, Michael
    Ziegelbauer, Karl
    Mumberg, Dominik
    CLINICAL CANCER RESEARCH, 2019, 25 (04) : 1404 - 1414
  • [44] Mechanistic In Vitro Studies Indicate that the Clinical Drug-Drug Interaction between Telithromycin and Simvastatin Acid Is Driven by Time-Dependent Inhibition of CYP3A4 with Minimal Effect on OATP1B1
    Elsby, Robert
    Hare, Victoria
    Neal, Hannah
    Outteridge, Samuel
    Pearson, Catherine
    Plant, Katie
    Gill, Rachel Upcott
    Butler, Philip
    Riley, Robert J.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (01) : 1 - 8
  • [45] Uridine 5′-Diphospho-glucuronosyltransferase 1A3 (UGT1A3) Prediction of Hepatic Clearance of Organic Anion Transporting Polypeptide 1B3 (OATP1B3) Substrate Telmisartan by Glucuronidation Using In Vitro-In Vivo Extrapolation (IVIVE)
    Gabor-Worwa, Ewelina
    Kowal-Chwast, Anna
    Gaud, Nilesh
    Gogola, Dawid
    Littlewood, Peter
    Smoluch, Marek
    Brzozka, Krzysztof
    Kus, Kamil
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2024, 49 (03) : 393 - 403
  • [46] Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model (vol 107, pg 655, 2006)
    Menu, E.
    Jernberg-Wiklund, H.
    Stromberg, T.
    BLOOD, 2011, 117 (12) : 3476 - 3476
  • [47] Paullones, a series of cyclin-dependent kinase inhibitors: Synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity
    Schultz, C
    Link, A
    Leost, M
    Zaharevitz, DW
    Gussio, R
    Sausville, EA
    Meijer, L
    Kunick, C
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (15) : 2909 - 2919
  • [48] Neurotherapeutic effects of novel HO-1 inhibitors in vitro and in a transgenic mouse model of Alzheimer's disease (vol 171, pg 778, 2014)
    Gupta, A.
    Lacoste, B.
    Pistell, Paul J.
    JOURNAL OF NEUROCHEMISTRY, 2014, 131 (06) : 878 - 878
  • [49] LRIG1 Enhances Chemosensitivity by Modulating BCL-2 Expression and Receptor Tyrosine Kinase Signaling in Glioma Cells (vol 55, pg 1196, 2014)
    Guo, Z.
    YONSEI MEDICAL JOURNAL, 2014, 55 (06) : 1748 - 1748
  • [50] Ovarian Cancer Cells, not Normal Cells, Are Damaged by Mirk/Dyrk1B Kinase Inhibition (vol 132, pg 2258, 2013)
    Hu, J.
    Deng, H.
    Friedman, E. A.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (06) : E13 - E13
12345